Alignment Healthcare, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 1.17B | 1.43B | 1.82B | 2.70B | 3.95B | 46.1% | |
| Cost of Revenue | (1.04B) | (1.25B) | (1.62B) | (2.41B) | (3.46B) | 43.8% | |
Gross Profit | 128.73M | 184.28M | 201.03M | 296.69M | 488.56M | 64.7% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (290.99M) | (295.65M) | (307.43M) | (371.37M) | — | -100.0% | |
| Depreciation & Amortization | (16.03M) | (17.49M) | (21.67M) | (27.06M) | (30.48M) | 12.6% | |
Operating Income (EBIT) | -178.07M | -128.64M | -127.82M | -101.56M | 14.75M | -114.5% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (17.44M) | (18.29M) | (21.23M) | (23.55M) | (15.80M) | -32.9% | |
| Other Income/Expenses (Net) | -17.21M | -20.66M | -20.38M | -26.50M | -15.71M | -40.7% | |
Income Before Tax | -195.29M | -149.30M | -148.19M | -128.05M | -958.00K | -99.3% | |
| Income Tax Expense | — | (339.00K) | (22.00K) | (21.00K) | (20.00K) | -4.8% | |
Net Income | -195.29M | -149.55M | -148.02M | -128.03M | -724.00K | -99.4% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-1 | $-1 | $-1 | $-1 | $-0 | -99.4% | |
| Weighted Avg Shares Outstanding | 171.96M | 181.21M | 186.21M | 190.79M | 198.01M | 3.8% | |
| Weighted Avg Shares Outstanding (Diluted) | 171.96M | 181.21M | 186.21M | 190.79M | 198.01M | 3.8% | |
EBITDA | -161.81M | -113.53M | -105.30M | -77.44M | 45.32M | -158.5% |
Explore ALHC
ALHC in the Healthcare
Mid Cap